IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Rossijskij Bioterapevticeskij Zurnal

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

0.16

h-Index

2024-2025

 6

Rank

2024-2025

 27780

SJR

2024-2025

 0.116

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Rossijskij Bioterapevticeskij Zurnal
Abbreviation Ross. Bioterapevticeskij Z.
Publication Type Journal
Subject Area, Categories, Scope Applied Microbiology and Biotechnology (Q4); Cancer Research (Q4); Immunology (Q4); Oncology (Q4)
h-index 6
Overall Rank/Ranking 27780
SCImago Journal Rank (SJR) 0.116
Impact Score 0.16
Publisher ABV-press Publishing House
Country Russian Federation
ISSN 17269792, 17269784
Best Quartile Q4
Coverage History 2019-2024




About Rossijskij Bioterapevticeskij Zurnal


Rossijskij Bioterapevticeskij Zurnal is a journal covering the technologies/fields/categories related to Applied Microbiology and Biotechnology (Q4); Cancer Research (Q4); Immunology (Q4); Oncology (Q4). It is published by ABV-press Publishing House. The overall rank of Rossijskij Bioterapevticeskij Zurnal is 27780. According to SCImago Journal Rank (SJR), this journal is ranked 0.116. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 6. The best quartile for this journal is Q4.

The ISSN of Rossijskij Bioterapevticeskij Zurnal journal is 17269792, 17269784. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Rossijskij Bioterapevticeskij Zurnal is cited by a total of 24 articles during the last 3 years (Preceding 2024).


Rossijskij Bioterapevticeskij Zurnal Impact IF 2024-2025


The Impact IF 2024 of Rossijskij Bioterapevticeskij Zurnal is 0.16, which is computed in 2025 as per its definition. Rossijskij Bioterapevticeskij Zurnal IF is decreased by a factor of 0.13 and approximate percentage change is -44.83% when compared to preceding year 2023, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Rossijskij Bioterapevticeskij Zurnal Impact IF 2025 Prediction


Impact IF 2024 of Rossijskij Bioterapevticeskij Zurnal is 0.16. If the same downward trend persists, Impact IF may fall in 2025 as well.


Impact IF Trend


Year wise Impact IF of Rossijskij Bioterapevticeskij Zurnal. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 0.16
2023 0.29

Rossijskij Bioterapevticeskij Zurnal h-index


  Table Setting

Rossijskij Bioterapevticeskij Zurnal has an h-index of 6. It means 6 articles of this journal have more than 6 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Rossijskij Bioterapevticeskij Zurnal ISSN


The ISSN of Rossijskij Bioterapevticeskij Zurnal is 17269792, 17269784. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Rossijskij Bioterapevticeskij Zurnal Rank and SCImago Journal Rank (SJR)


The overall rank of Rossijskij Bioterapevticeskij Zurnal is 27780. According to SCImago Journal Rank (SJR), this journal is ranked 0.116. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Rossijskij Bioterapevticeskij Zurnal by Year


Year SJR
2025/2026 Coming Soon
2024 0.116
2023 0.134

Ranking of Rossijskij Bioterapevticeskij Zurnal by Year


Year Ranking
2025/2026 Coming Soon
2024 27780
2023 24155

Rossijskij Bioterapevticeskij Zurnal Publisher


Table Setting

Rossijskij Bioterapevticeskij Zurnal is published by ABV-press Publishing House. It's publishing house is located in Russian Federation. Coverage history of this journal is as following: 2019-2024. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Rossijskij Bioterapevticeskij Zurnal is Ross. Bioterapevticeskij Z.. This abbreviation ('Ross. Bioterapevticeskij Z.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Rossijskij Bioterapevticeskij Zurnal


If your research field is/are related to Applied Microbiology and Biotechnology (Q4); Cancer Research (Q4); Immunology (Q4); Oncology (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Rossijskij Bioterapevticeskij Zurnal?

Rossijskij Bioterapevticeskij Zurnal latest impact IF is 0.16. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 0.29 (2023) and 0.16 (2024), respectively, in the last 2 years. Moreover, its average IS is 0.23 in the previous 2 years.


What's the SCImago Journal Rank (SJR) of the Rossijskij Bioterapevticeskij Zurnal?

The Rossijskij Bioterapevticeskij Zurnal has an SJR (SCImago Journal Rank) of 0.116, according to the latest data. It is computed in the year 2025. In the past 2 years, this journal has recorded a range of SJR, with the highest being 0.134 in 2023 and the lowest being 0.116 in 2024. Furthermore, the average SJR of the Rossijskij Bioterapevticeskij Zurnal over the previous 2-year period stands at 0.23.


What's the latest h-index of the Rossijskij Bioterapevticeskij Zurnal?

The latest h-index of the Rossijskij Bioterapevticeskij Zurnal is 6.


Who's the publisher of the Rossijskij Bioterapevticeskij Zurnal?

The Rossijskij Bioterapevticeskij Zurnal is published by the ABV-press Publishing House, with its country of publication being the Russian Federation.


What's the current ranking of the Rossijskij Bioterapevticeskij Zurnal?

The Rossijskij Bioterapevticeskij Zurnal is currently ranked 27780 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 2 years, this journal has experienced varying rankings, reaching its highest position of 24155 in 2023 and its lowest position of 27780 in 2024.


What's the abbreviation or short name for the Rossijskij Bioterapevticeskij Zurnal?

The standard ISO4 abbreviation for the Rossijskij Bioterapevticeskij Zurnal is Ross. Bioterapevticeskij Z..


Is the "Rossijskij Bioterapevticeskij Zurnal" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Rossijskij Bioterapevticeskij Zurnal is classified as a journal that the ABV-press Publishing House publishes.


What's the scope or major areas of the Rossijskij Bioterapevticeskij Zurnal?

The Rossijskij Bioterapevticeskij Zurnal encompasses the following areas:

  • Applied Microbiology and Biotechnology
  • Cancer Research
  • Immunology
  • Oncology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Rossijskij Bioterapevticeskij Zurnal?

The Rossijskij Bioterapevticeskij Zurnal is assigned the following International Standard Serial Numbers (ISSN): 17269792, 17269784.


What's the best quartile of the Rossijskij Bioterapevticeskij Zurnal?

The best quartile for the Rossijskij Bioterapevticeskij Zurnal is Q4 (2024).


What's the coverage history of the Rossijskij Bioterapevticeskij Zurnal?

The Rossijskij Bioterapevticeskij Zurnal coverage history can be summarized as follows: 2019-2024.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Indian Journal of Plastic Surgery journal 30965 Georg Thieme Verlag 44 0.46
Journal of International Financial Management and Accounting journal 1434 Wiley-Blackwell Publishing Ltd 50 10.53
Built Environment journal 16252 Alexandrine Press 51 0.95
Metascience journal 24313 Springer Nature 3 0.00
Revista de Metodos Cuantitativos para la Economia y la Empresa journal 24107 Universidad Pablo de Olavide 12 0.54
Asian Nursing Research journal 7771 Korean Society of Nursing Science 45 2.79
Himalayan Geology journal 19942 Wadia Institute of Himalayan Geology 20 0.89
Acta Colombiana de Psicologia journal 20042 Universidad Catolica de Colombia 18 0.67
Journal of Simulation journal 14980 Taylor and Francis Ltd. 34 2.41
Psicologia Clinica journal 26055 Pontificia Universidade Catolica do Rio de Janeiro 10 0.00

Check complete list




Year wise Impact Score (IS) of Rossijskij Bioterapevticeskij Zurnal

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 0.16
2023 0.29



Top Journals/Conferences in Applied Microbiology and Biotechnology

Nature Biotechnology
Nature Research | United Kingdom

Nature Reviews Bioengineering
Springer Nature | United Kingdom

Nature Microbiology
Nature Research | United Kingdom

International Journal of Biological Sciences
Ivyspring International Publisher | Australia

Biotechnology Advances
Elsevier Inc. | United States

npj Biofilms and Microbiomes
Nature Publishing Group | United Kingdom

Reviews in Environmental Science and Biotechnology
Springer Science and Business Media B.V. | Netherlands

Journal of Nanobiotechnology
BioMed Central Ltd | United Kingdom

Critical Reviews in Biotechnology
Informa Healthcare | United Kingdom

Current Opinion in Food Science
Elsevier Ltd | United Kingdom

See All

Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Nature Cancer
Nature Research | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins | United States

Journal of Hematology and Oncology
BioMed Central Ltd | United Kingdom

Molecular Cancer
BioMed Central Ltd | United Kingdom

JAMA Oncology
American Medical Association | United States

Cell Host and Microbe
Cell Press | United States

Neuro-Oncology
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Immunology

Nature Reviews Immunology
Nature Research | United Kingdom

Annual Review of Immunology
Annual Reviews Inc. | United States

Nature Reviews Microbiology
Nature Research | United Kingdom

Immunity
Cell Press | United States

Nature Immunology
Nature Research | United Kingdom

Science immunology
American Association for the Advancement of Science | United States

Cell Host and Microbe
Cell Press | United States

Nature Microbiology
Nature Research | United Kingdom

Cellular and Molecular Immunology
Springer Nature | United Kingdom

Journal of Experimental Medicine
Rockefeller University Press | United States

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
John Wiley and Sons Inc | United States

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Annals of Oncology
Elsevier Ltd | United Kingdom

Cancer Cell
Cell Press | United States

Nature Cancer
Nature Research | United States

Lancet Oncology, The
Elsevier Ltd | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins | United States

Journal of Hematology and Oncology
BioMed Central Ltd | United Kingdom

Molecular Cancer
BioMed Central Ltd | United Kingdom

See All